Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05371509 · ClinicalTrials.gov registry record · NA

Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT05371509: Completed NA study, sponsored by Mayo Clinic.

NCT05371509 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05371509, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

This research study is being done to determine whether the repetition and resistance from the daily use of the myofunctional therapy (MT) nozzle will improve obstructive sleep apnea and primary snoring.

Interventions

  • DEVICE Myofunctional therapy (MT) nozzle
  • OTHER Placebo nozzle

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2023-09-07
Est. Completion 2024-12-10
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05371509

The ClinicalTrials.gov registry entry for NCT05371509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Myofunctional therapy (MT) nozzle is the first listed.

NCT05371509 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05371509 about?

NCT05371509 is a clinical study titled "Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study". This research study is being done to determine whether the repetition and resistance from the daily use of the myofunctional therapy (MT) nozzle will improve obstructive sleep apnea and primary snoring.

What is the current status of trial NCT05371509?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2023-09-07. Estimated completion is 2024-12-10.

What interventions are being tested in trial NCT05371509?

The interventions under investigation include: Myofunctional therapy (MT) nozzle (DEVICE), Placebo nozzle (OTHER).

Who is sponsoring clinical trial NCT05371509?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.